Please Wait...

Bioclinica Announces Senior Leadership Change

Euan Menzies, Chairman of Board of Directors, Named Executive Chairman and Interim CEO | President and CEO David Herron to Step Down

December 20, 2019

PRINCETON, N.J., December 20, 2019 – Bioclinica, a leading provider of clinical science and
technology expertise to assist the life science industry, today announces that David Herron,
Bioclinica’s President and Chief Executive Officer, will be leaving the company to pursue other
business interests. Euan Menzies, the Chairman of Bioclinica’s Board of Directors, will assume the
role of Executive Chairman and interim Chief Executive Officer. To ensure a seamless transition of
leadership responsibilities, Mr. Herron will remain with the Company in an advisory capacity until
the end of January 2020.
“On behalf of everyone at Bioclinica, I would like to thank David for his significant contributions to
the company,” said Menzies. “During the past several years, Bioclinica has achieved numerous
milestones, including improved financial performance and the broadening of its global presence.
We have an exceptional leadership and employee team; and are now well positioned to accelerate
the pace of investment and growth as we continue to deliver meaningful value for our clients.”

Media Contact
 

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. The company's offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance, and trial management. The company's thousands of employees serve more than 500 pharmaceutical, biotechnology and device organizations – including all top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.

 

###

 

Media Contact
Nicole Klatsky
+1 (609) 865-5212
nicole.klatsky@bioclinica.com

 

 

Learn more about Bioclinica at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in… https://t.co/W5swfW70Ws
Bioclinica (3 days ago)
Not sure what questions to ask your clinical adjudication provider when transitioning a project to a new provider?… https://t.co/Tb2TXXuNa9
Bioclinica (4 days ago)
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/whD4O3w6QB
Bioclinica (1 week ago)
Save time and minimize risk with Bioclinica’s Clinical Trial Management System (CTMS) Starter Package. A fully feat… https://t.co/AgcXHWCg80
Bioclinica (2 weeks ago)
It takes a village to manage #clinicaltrial data. Watch our video to learn how to leverage our Clinical… https://t.co/F7yof0B6zH
Bioclinica (2 weeks ago)
The Clinical Trial Management System (CTMS) Starter Package from Bioclinica saves time and minimizes the risk often… https://t.co/EDhe0Qokla
Bioclinica (3 weeks ago)